I n t e g r a t e d
R e p o r t
2021
Headquarters:
11 Kamitakamatsu-cho, Fukuine, Higashiyama-ku, Kyoto 605-0983, Japan
Phone: +81-75-561-0411
The major role of dentistry is to support people's ability to live by maintaining oral functions at all stages of life so that they can perform the basic activities of eating and speaking.
Whereas medicine is medical care for life, dentistry is medical care for living. Through the development of superior dental materials and equipment, we aim to contribute to better dental care together with dental professionals and doctors involved in dental education.
[Corporate Philosophy]
Contribution to dentistry through innovative business activities
[The Origin of Our Management ̶ The Founder's Vision] "The Japanese must eat rice with teeth made by the Japanese."
Shofu's history began in 1922 about a hundred years ago. In the era of valuing imported goods when dental care depended mainly on imported goods from Europe and the United States, Kajo Shofu III, the founder, established SHOFU DENTAL Mfg. Co., Ltd. with high aspirations after he succeeded in domestic production of high-quality porcelain teeth.
In 1890, the founder Kajo Shofu III married into the Shofu family, a well-known member of the ceramics industry. Based on the Kiyomizu-ware technique, he was involved in many businesses, including exporting ceramics, industrializing ceramic manufacturing, and entering the insulator business.
In 1915 when he visited North America to expand sales channels for export ceramics, he met Dr. Mitsuru Okada (later professor of oral surgery at Keio University School of Medicine), who strongly persuaded him to produce high-quality porcelain teeth in Japan. Stemming from his desire to contribute to people's oral health and society, he decided to develop high-quality porcelain teeth on
his own.
Learn about Shofu | Value Creation Story | Business Strategy | ESG | Financial Data and Company Profile |
CON T E N T S
Learn about | Financial and Non-financial Highlights | 3 |
Shofu | Shofu's History of Value Creation | 5 |
Global Network | 7 | |
Value Creation | Shofu's Value Creation Process | 9 |
Story | Shofu's Value Chain | 11 |
Message from the President | 13 | |
The Shofu Group's Medium-term Management Plan | 17 | |
Executive Vice President's Message | 19 | |
Business | Shofu's Core Competence | 21 |
Strategy | Business Overview (Dental Business) | 23 |
Special Feature: Developing unique technologies and products to meet customers' | ||
needs backed by research and development capabilities we have | ||
built since our establishment | 25 | |
Business Overview (Nail Care Business/Other Businesses) | 26 | |
ESG | Corporate Governance | 27 |
Compliance | 32 | |
Environment | 33 | |
Society | 35 | |
Financial Data | Financial Summary for Past 11 Years | 39 |
and Company | Company Profile and Stock Information | 41 |
Profile |
The development of high-quality porcelain teeth was no easy task as he faced many challenges to overcome, such as how to find a form that suits the Japanese and materials that can be used in the oral cavity, and how to produce them. However, with support from many people he finally made his dream come true after years of struggles and failures.
The founder's passion̶to have high ambitions and achieve them̶has been handed down from generation to generation and has now become the foundation of our strong focus on research and development.
Japan's first high-quality porcelain | |
Kajo Shofu III, the founder | teeth developed by Shofu |
Corporate communications
Overview | Financial information | Non-financial information |
Integrated Report |
Shareholder Report
Materials for financial results briefing
Corporate Governance Report
Details | Materials for financial results | |
(including Annual Securities Report, etc.) | ||
Corporate website | ||
Visit our website for mode detailed financial and non-financial information and figures. https://www.shofu.com/global/
Editorial policy
We prepared this integrated report in the hope that our shareholders, investors, and other stakeholders will deepen their understanding of our social and economic value creation through reporting on our management strategies, business activities, and ESG activities, among others. We will continue to use this integrated report as a communication tool with our stakeholders.
In editing this report, we have referred primarily to the "Guidance for Collaborative Value Creation" by the Ministry of Economy, Trade and Industry of Japan.
Period covered by the report
Fiscal year ended March 31, 2021 (April 1, 2020 through March 31, 2021) is the primary period covered by this report.
* The report includes information for periods before or after the period above.
Scope covered by the report
SHOFU INC. and its consolidated subsidiaries (Some activities are relevant to SHOFU INC. alone.)
Forward-looking statements
Forward-looking information in this report including earnings forecasts is based on projections and forecasts in light of information currently available to us and is subject to potential risks and uncertainties, among other factors. As a result, actual results may differ materially from those we currently anticipate due to changes in various factors.
1 | SHOFU INC | Integrated Report 2021 | 2 |
Financial and Non-financial Highlights
Learn about Shofu | Value Creation Story | Business Strategy | ESG | Financial Data and Company Profile |
Financial Indicators
Net sales/Overseas net sales/ Overseas sales ratio
Net sales | Overseas net sales | Overseas sales ratio | ||
(Left axis) | (Left axis) | (Right axis) |
24,680 | 10,946 | 44.4% | ||||
million yen | million yen | |||||
(Millions of yen) | (%) | |||||
30,000 | 24,915 | 26,108 | 24,680 | 60 | ||
24,031 | ||||||
22,305 | 44.0 | |||||
43.2 | 45.3 | 44.4 | ||||
20,000 | 40.9 | 40 | ||||
10,000 | 9,116 | 10,378 | 11,295 | 11,499 | 10,946 | 20 |
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Operating income/
Operating profit margin
Operating income | Operating profit margin | |
(Left axis) | (Right axis) |
2,300million yen | 9.3% | |||||
(Millions of yen) | (%) | |||||
2,500 | 2,210 | 2,300 | 25 | |||
2,000 | 1,814 | 20 | ||||
1,500 | 1,382 | 1,497 | 15 | |||
1,000 | 6.2 | 6.2 | 7.3 | 8.5 | 9.3 | 10 |
500 | 5 | |||||
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Profit attributable to owners of parent/ Payout ratio
Profit attributable to owners of parent | Payout ratio | |
(Left axis) | (Right axis) |
1,674million yen | 30.1% | |||||
(Millions of yen) | 58.8 | (%) | ||||
2,000 | 60 | |||||
1,674 | ||||||
1,500 | 38.0 | 36.2 | 1,201 | 45 | ||
1,000 | 836 | 877 | 30.4 | 704 | 30.1 | 30 |
500 | 15 | |||||
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Non-financial Indicators
R&D expenses/
Ratio of R&D expenses to net sales
R&D expenses | R&D expenses ratio | |
(Left axis) | (Right axis) |
1,563million yen | 6.3% | |||||
(Millions of yen) | (%) | |||||
2,000 | 20 | |||||
1,500 | 1,408 | 1,494 | 1,492 | 1,537 | 1,563 | 15 |
1,000 | 6.3 | 10 | ||||
6.2 | 6.0 | 5.9 | 6.3 | |||
500 | 5 | |||||
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Equity ratio | Equity/Return on equity (ROE) |
Equity (Left axis) | ROE (Right axis) | ||||||||||
79.4% | 30,024million yen | 6.2% | |||||||||
(%) | 80.4 | 79.7 | (Millions of yen) | (%) | |||||||
80 | 79.4 | 40,000 | 8 | ||||||||
77.8 | 30,024 | ||||||||||
76.9 | |||||||||||
24,035 | 24,250 | 23,786 | 6.2 | ||||||||
75 | 30,000 | 22,185 | 6 | ||||||||
20,000 | 3.8 | 3.8 | 5.0 | 2.9 | 4 | ||||||
70 | 10,000 | 2 | |||||||||
0 | 0 | 0 | |||||||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 | FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Average years of service/
Job turnover ratio
Average years of service | Job turnover ratio | |||
(Left axis) | (Right axis) | |||
17.57years | 1.4% |
(Years) | (%) | |||||
20 | 17.48 | 17.61 | 17.87 | 17.77 | 17.57 | 4 |
15 | 2.4 | 2.4 | 3 | |||
10 | 1.7 | 2 | ||||
1.0 | 1.4 | |||||
5 | 1 | |||||
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
- The job turnover ratio does not include employees who have reached the mandatory retirement age.
Average monthly overtime hours per employee
6.09hours | |||
(Hours) | |||
12 | 10.33 | ||
9.28 | |||
8.80 | |||
8 | 7.45 |
6.09
4
0
FY2017/3 FY2018/3 FY2019/3 FY2020/3 FY2021/3
Total assets/Return on assets (ROA)
Total assets (Left axis) | ROA (Right axis) | |
37,813million yen | 4.9% | |||||
(Millions of yen) | (%) | |||||
40,000 | 37,813 | 6 | ||||
30,000 | 28,853 | 30,890 | 30,161 | 29,834 | 4.9 | |
3.9 | 4 | |||||
2.9 | 2.9 | |||||
20,000 | 2.3 | |||||
10,000 | 2 | |||||
0 | 0 | |||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Cash flows from operating activities
2,829million yen
(Millions of yen)
3,000 | 2,829 | |||
2,308 | 1,942 | |||
2,000 | 1,936 | |||
1,468 | ||||
1,000 | ||||
0 | ||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Number of patents held
378patents
(Patents) | 380 | 389 | ||
400 | 358 | 378 | ||
336 | ||||
300 | ||||
200 | ||||
100 | ||||
0 | ||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
Number of overseas employees/ Ratio of overseas employees
Number of overseas employees | Ratio of overseas employees | ||
(Left axis) | (Right axis) | ||
564persons | 46.7% |
(Persons) | (%) | ||||
600 | 522 | 561 | 567 | 564 | |
509 | 46.5 | 47.0 | 50 | ||
41.6 | 43.2 | 46.7 | |||
400 | 40 | ||||
30 | |||||
200 | 20 | ||||
10 | |||||
0 | 0 | ||||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
- Non-financialindicators are on a non-consolidated basis (except for the number of overseas employees and the ratio of overseas employee, which are on a consolidated basis).
3 | SHOFU INC | Integrated Report 2021 | 4 |
Learn about Shofu | Value Creation Story | Business Strategy | ESG | Financial Data and Company Profile |
Shofu's history of value creation
Since its establishment in 1922, the founder's passion̶to have high ambitions and achieve them̶has been handed down as Shofu's DNA. With such background, we have been leading the dental industry by developing many products that were the first of their kind either in Japan or in the world. Going forward, we will continue to take on new challenges to cater for ever-changing needs of society.
1983
Changed the Company's name to SHOFU INC. and conducted management reforms.
1985
Developed and began selling the Japan's first light-cured composite resin, Lite-Fil.
1986
Developed and began selling hybrid resin teeth, Endura̶new generation artificial teeth.
1987
1991
Acquired ADVANCED HEALTHCARE LTD., a dental material manufacturer in the U.K.
1997
Completed a new research center, the most advanced facility in the dental industry. Obtained CE Marking certification.
2003
Established a manufacturing subsidiary, SHANGHAI SHOFU DENTAL MATERIAL CO., LTD. in China.
2012
Listed on the First Section of the Tokyo Stock Exchange.
2015
Purchased MERZ DENTAL GmbH and made it a subsidiary, which is a manufacturer of artificial teeth in Germany.
2017
Established a sales subsidiary, SHOFU DENTAL BRASIL COMERCIO DE PRODUTOS ODONTOLOGICOS LTDA. in Brazil.
1922
The first president, Kajo Shofu III, established SHOFU DENTAL Mfg. Co., Ltd. Began manufacture and sale of artificial teeth and research and development of dental materials.
Photos of the Company at the time of establishment. Shofu developed Japan's first products one after another.
1952
Developed and began selling Japan's first diamond abrasives and vacuum fired porcelain teeth.
1955
Opened TOKYO SALES OFFICE in
Azumabashi, Sumida-ku, Tokyo.
1956
Completed the laboratory building.
1963
Registered shares as over-the-counter stock to
1971
Established a sales subsidiary, SHOFU DENTAL CORPORATION in California, U.S.
1973
Established SHIGA SHOFU INC. in
Shigaraki-cho,Koga-gun, Shiga (currently,
Shigaraki-cho,Koga-shi, Shiga).
Liquidated SHOFU DENTAL SINGAPORE and opened SINGAPORE SALES OFFICE (currently, SHOFU DENTAL ASIA-PACIFIC PTE. LTD.).
1989
Listed on the Second Section of the Osaka Securities Exchange and on the Kyoto Stock Exchange.
2005
Established a sales subsidiary, SHOFU DENTAL (SHANGHAI) CO., LTD. in China. (currently, SHOFU DENTAL TRADING (SHANGHAI) CO., LTD.)
2007
Listed on the Second Section of the Tokyo Stock Exchange.
2008
Purchased NAIL LABO CORPORATION and made it a subsidiary, which imports and sells materials and equipment for professional nail care specialists.
Established a sales subsidiary, SHOFU DENTAL INDIA PRIVATE LIMITED in India.
2020
Enhanced the business and capital tie-up with Mitsui Chemicals, Inc. and Sun Medical Co., Ltd.
Established a manufacturing subsidiary, SHOFU PRODUCTS VIETNAM CO., LTD. in
Vietnam. | (Billions of yen) | ||
30.0 |
1937
Developed and began selling the Japan's first palladium alloy, SHOFU Palladium S.
1939
Opened the SHOFU Showroom at Ginza 1-chome, Tokyo.
1945
Developed and began selling Japan's first resin teeth.
Osaka Prefecture Association of Japan Securities Dealers Association.
1965
Began selling the world's first dental spherical amalgam, SHOFU Spherical Amalgam.
1976
Established the Shofu Dental Club.
1978
Established a sales subsidiary, SHOFU DENTAL GmbH in the suburbs of Dusseldorf, Germany.
1980
Established a sales subsidiary, SHOFU DENTAL SINGAPORE in Singapore.
25.0 | |||||||||||
2009 | 20.0 | ||||||||||
Concluded a business and capital tie-up with | |||||||||||
Mitsui Chemicals, Inc. and Sun Medical Co., Ltd. | |||||||||||
Prevention and aesthetic awareness were increased in public | 15.0 | ||||||||||
The revised Pharmaceutical | |||||||||||
Affairs Act was enforced(2005) | |||||||||||
Medical fees were revised. | 10.0 | ||||||||||
Largest reduction in history(2006) | |||||||||||
Patients' burden of | |||||||||||
Advancement of | |||||||||||
medical expenses | digitization in dentistry | ||||||||||
increased | 5.0 | ||||||||||
Era when imported | High-growth period driven by the | |||||||||||||||||||||||||||||||||
goods were valued | spread of the health insurance system | Entering | an | aging society | ||||||||||||||||||||||||||||||
1922 (Established) | 1959 1960 | 1970 | 1980 |
Policies to control medical costs/ Period of low growth
1990
From 10% to 20% (1997) | ||||
The dental market expanded in emerging | ||||
From 20% to 30% (2003) | countries due to population growth and | |||
growing economy | ||||
0 | ||||
2000 | 2010 | 2020 (FY) |
* Figures for FY1999 and thereafter refer to consolidated net sales.
1922 ‒ 1951 | 1952 ‒ 1970 |
SHOFU DENTAL Mfg. Co., Ltd. | Became a leading company of |
started business | the dental industry |
Shofu's products that have been serving social needs
1971 ‒ 1982 | 1983 ‒ 1989 | 1990 ‒ 2011 | 2012 and beyond |
Expanded to the overseas market | Boldly implemented | Moved forward as a listed company | To be a 100-year company |
management reforms | |||
Japan's first high-quality porcelain teeth SHOFU Anatome Form
The world's first dental spherical amalgam | Cement with HY agent | Japan's first hybrid resin teeth | Light-curing C+B Composite | Digital oral cavity photography device |
SHOFU Spherical Amalgam | HY-Bond Carbo Cement | Endura | SOLIDEX | EyeSpecial C-II |
Most artificial | In the 1960s, Shofu | In 1980, Shofu | After the | During this period, | A digital oral |
teeth used in | worked to develop | developed | management | competitors | cavity |
dentistry in | products that are | dental | reforms, Shofu | already launched | photography |
Japan were | competitive in the | cements with | succeeded to | light-cured hard | device used |
made in the U.S. | global market, and as | HY agent, | develop Endura in | resin used to create | when obtaining |
or Europe and | a result, succeeded to | which | 1986, Japan's first | resin-made | informed |
they were not | launch dental | contains | hybrid resin teeth, | prosthetic | consent from |
designed to fit the Japanese bone structure. | spherical amalgam | tannin, a | using newly | restorations such as | patients or |
To meet the needs for high-quality porcelain | ahead of the rest of | material used | developed materials. Endura was highly rated | crowns and inlays. | making comparison before and after operation. |
teeth for Japanese people, the founder, Kajo | the world. We | for tooth-blackening dye. We applied HY agent | by the Japan Dental Association and the then | Shofu focused on | It allows users to take high-qualityintra-oral |
Shofu III, started full-scale research in | launched SHOFU Spherical Amalgam in 1965, | to various dental cement products according | Ministry of Health and Welfare for its | the operability and aesthetic quality of such | photographs with easy operation while being |
artificial teeth. With the cooperation of many | which immediately had a great impact on the | to the research results that HY agent is | biocompatible shape, color, and other | resin and succeeded to develop SOLIDEX. | lightweight and compact, and helps improve |
people involved, he succeeded to develop | dental materials industry in and outside Japan | expected to strengthen tooth structure like | characteristics, and adopted by the health | With SOLIDEX, we increased operability of | communication between dental professionals |
Japan's first high-quality porcelain teeth | as it was easy to be processed due to its | tooth blackening, which contributed to the | insurance by its brand name, succeeding in | dental technicians and achieved color | and patients. |
through a number of challenges. | spherical particles and small surface area. | prevention of dental caries in patients. | anticipating the demands of an aging society. | reproduction close to that of natural teeth. |
5 | SHOFU INC | Integrated Report 2021 | 6 |
Global Network
SHOFU DENTAL GmbH ●
MERZ DENTAL GmbH ●●
DIGITAL DENTAL SERVICES GmbH ●●
Learn about Shofu | Value Creation Story | Business Strategy | ESG | Financial Data and Company Profile |
Russia | |||||||||||||
(15,000 people) | |||||||||||||
ADVANCED HEALTHCARE LTD. ●● | Central Europe, Eastern Europe | ||||||||||||
Western Europe | Europe | (1,495 million dollars) | Japan | ||||||||||
(9,026 million dollars) | (453,000 people) | China | (102,000people) | ||||||||||
(144,000people) | |||||||||||||
Other Asian countries | |||||||||||||
(186,000 people) | |||||||||||||
SHOFU DENTAL MIDDLE EAST | Japan | ||||||||||||
& AFRICA OFFICE | (2,153million dollars) | ||||||||||||
Asia, Oceania | |||||||||||||
Middle East, Africa | India | (2,764 million dollars) | |||||||||||
(151,000 people) | (333,000people) | ||||||||||||
North America(794,000people)
Including America(770,000people)
NAIL LABO INC. ●
SHIGA SHOFU INC. ●
SHOFU INC. HEADQUARTERS/KYOTO SALES OFFICE
SHOFU PRODUCTS KYOTO INC. ●
FUKUOKA SALES OFFICE | ||
North America, Central | OSAKA SALES OFFICE | |
and South America | ||
(14,413 million dollars) | ||
SAPPORO SALES OFFICE SENDAI SALES OFFICE
TOKYO BRANCH SHOFU BIOFIX INC. ● NAIL LABO CORPORATION ●
NAGOYA SALES OFFICE
- Sales subsidiaries
- Manufacturing subsidiaries
- Nail care business subsidiaries
Number of dentists in the world: | Middle East, Africa | ||||
(703 million dollars) | |||||
Approximately 2.65 million | |||||
Estimated market size: | Oceania | ||||
Approximately 3.0 trillion yen | (23,000 people) | ||||
Number of dentists( | One icon represents 50,000 dentists.) | ||||
SHOFU DENTAL INDIA PRIVATE LIMITED ● | |||||
Source: Number of dentists, Estimated market size... | SHOFU DENTAL TRADING (SHANGHAI) CO., LTD. ● | ||||
"Worldwide Medical Devices Market Factbook 2019", BMI Research | SHANGHAI SHOFU DENTAL MATERIAL CO., LTD. ● | ||||
SHOFU DENTAL
CORPORATION ●
SHOFU MEXICO
S DE RL DE CV ●
SHOFU DENTAL
BRASIL COMERCIO
DE PRODUTOS
ODONTOLOGICOS LTDA. ●
NAIL LABO TAIWAN CO., LTD. ● SHOFU INC., TAIWAN BRANCH
SHOFU PRODUCTS VIETNAM CO., LTD. ● SHOFU DENTAL ASIA-PACIFIC PTE.LTD. ●
Central and South America(452,000 people)
Including Brazil(319,000 people)
Global dental equipment market: 30.5 billion dollars
Growth rate in the last 5 years: 4.9% per year
Dental equipment market size
Source: Global dental equipment market, Growth rate in the last 5 years… "Worldwide Medical Devices Market Factbook 2019", BMI Research
Shofu's network around the world | Overseas Sales/ |
Overseas Sales Ratio |
Dental business
Overseas sales (By region)
Unit: millions of yen,
[ ] shows component ratio
Since the 1970s, when we first expanded operations overseas, the Company Group has been promoting overseas
further increase our contribution to the world's dental care in order to realize the corporate philosophy.
Overseas sales (Millions of yen)
Dental business overseas sales ratio (%) Overseas sales ratio (%)
46.6 |
overseas sales ratio
45.1%
(Fiscal year ended
10,946 million yen (Fiscal year ended March 31, 2021)
■ North America/Central and South America | ■ Asia/Oceania and others |
Asia/Oceania and others
Europe
North America/Central and South America
expansion by making the most of our global network, which is centered in North America and Central and South America, Europe, as well as Asia and Oceania.
The Group currently sells Shofu's products in more than 100 countries, with overseas sales accounting for more than 40% of total sales. However, we have not been able to fully demonstrate our presence in the overseas market, which is about 14 times larger than the domestic market. We must
7 SHOFU INC
We are actively promoting the establishment of sales subsidiaries and manufacturing subsidiaries in order to capture demand not only in developed markets with high levels of dental care, but also in emerging markets.
In order to promote Shofu's products around the world, we will aim to expand overseas business by increasing the recognition of the Shofu's brand through the development and expansion of overseas sites.
43.5 | 45.2 | 45.1 | ||
45.3 | 44.0 | 44.4 | ||
41.3 | 43.2 | |||
40.9 | 11,295 | 11,499 | 10,946 | |
9,116 | 10,378 | |||
FY2017/3 | FY2018/3 | FY2019/3 | FY2020/3 | FY2021/3 |
March 31, 2021)
2,500 million yen
Year-on-year decrease of 394 million yen (-13.6%)
In North America and Central and South America, sales decreased by 394 million yen, or 13.6%, due to the struggling sales of almost all product groups, except for artificial teeth and nail products, as well as the negative impact of foreign exchange rates.
■ Europe
4,237million yen
Year-on-year increase of 111 million yen (+2.7%)
In Europe, sales increased by 111 million yen, or 2.7%, due to flexible efforts in sales of disposable masks and gloves, as well as the positive impact of foreign exchange rates.
4,208 million yen
Year-on-year decrease of 270 million yen (-6.0%)
In Asia and Oceania and others, overall sales decreased by 270 million yen, or 6.0%.
By district, sales in China decreased by
24 million yen, or 1.0%, due to the negative impact of foreign exchange rates, although sales in China increased on a local currency basis due to strong sales of chemical products.
Sales in elsewhere in Asia decreased by 246 million yen, or 12.0%, as a result of weak sales in all product groups except nail products due to the significant decline in sales in emerging countries including ASEAN countries and India, despite strong sales in South Korea and Taiwan.
11,499 10,946
4,479 | 4,208 | |
[ 38.9 % ] | ||
[ 38.4 % ] | ||
4,125 | ||
4,237 | ||
[ 35.9 % ] | ||
[ 38.7 % ] | ||
2,895 | ||
2,500 | ||
[ 25.2 % ] | [ 22.9 % ] | |
FY2020/3 | FY2021/3 |
Integrated Report 2021 | 8 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Shofu Inc. published this content on 30 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 November 2021 15:50:03 UTC.